Health systems worldwide face growing pressure from population ageing and the rising burden of noncommunicable diseases. Yet policy debates still focus mainly on how much is spent, while paying much less attention to when health systems invest. In many settings, spending remains concentrated in late-stage curative care, whereas earlier phases of the life course, when risks are still developing and remain modifiable, receive less sustained investment. We describe this mismatch as a temporal imbalance: a misalignment between when health risks accumulate and when resources are allocated. We argue that the pattern persists because institutions are usually rewarded for responding to visible burden, while the returns to earlier intervention are delayed, diffuse, and harder to attribute. As a result, organisations that invest early often cannot readily claim the later benefits of doing so. This creates a temporal accountability gap. Drawing on life-course epidemiology, health financing research, clinical perspectives from endocrinology and palliative care, and illustrative expenditure data from Hebei Province, China, we examine timing as an overlooked dimension of health policy and propose three practical policy actions: routine life-course expenditure reporting, longer evaluation horizons for prevention, and financing mechanisms that reward earlier investment.
Tian et al. (Fri,) studied this question.